Pharmacokinetic Food-effect Study of Abiraterone Acetate (A.A) in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Abiraterone acetate (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Pharmacokinetics
- Acronyms Abifood01
- 08 Jan 2021 Status changed from active, no longer recruiting to completed.
- 11 Feb 2020 Planned End Date changed from 1 Mar 2020 to 12 Apr 2020.
- 11 Feb 2020 Planned primary completion date changed from 1 Dec 2019 to 12 Apr 2020.